^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AB-1015

    i
    Associations
    News

    Trials

    Company:
    ArsenalBio
    Drug class:
    Mesothelin-targeted CAR-T immunotherapy, ALPP-targeted CAR-T immunotherapy, ALPPL2-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News

    Trials

    Apply
    AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer (NCT05617755)
    Phase 1
    Arsenal Biosciences, Inc.
    Recruiting
    Last update posted :
    05/07/2024
    Initiation :
    11/29/2022
    Primary completion :
    12/01/2024
    Completion :
    02/01/2027
    BRCA1 • BRCA2 • MUC16
    |
    BRCA2 mutation • BRCA1 mutation
    |
    cyclophosphamide • AB-1015